Sunshine Biopharma (SBFM) Current Leases (2019 - 2026)
Sunshine Biopharma (SBFM) reported Current Leases of $209226.0 for Q1 2026, down 2.22% on a YoY basis from $213983.0 in Q1 2025, and down 2.97% quarter-over-quarter from $215637.0 in Q4 2025.
Sunshine Biopharma (SBFM) Current Leases (2019 - 2026) Analysis & Trends
Sunshine Biopharma has reported Current Leases for 6 years, with the latest figure at $209226.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases fell 2.22% year-over-year to $209226.0; the trailing twelve-month figure through Mar 2026 stood at $209226.0 (down 2.22% YoY), and the FY2025 full-year result was $215637.0, up 3.79% from the prior year.
- Current Leases for Q1 2026 stood at $209226.0, down from $215637.0 in the prior quarter.
- The five-year high for Current Leases was $222496.0 in Q2 2025, with the low at $114452.0 in Q2 2024.
- Historically, Current Leases has averaged $159731.4 across 5 years, with a median of $122586.0 in 2022.
- Annual changes were most pronounced in 2024 — Current Leases dropped 6.3% — and 2025, when it jumped 94.4%.
- Sunshine Biopharma's Current Leases stood at $123026.0 in 2022, then decreased by 3.54% to $118670.0 in 2023, then jumped by 75.07% to $207756.0 in 2024, then grew by 3.79% to $215637.0 in 2025, then slipped by 2.97% to $209226.0 in 2026.
- The last three Current Leases figures came in at $209226.0 (Q1 2026), $215637.0 (Q4 2025), and $218053.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 23.81 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 7.58 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 5.58 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn | 209,226.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209,226.00 |
| Dec 31, 2025 | 215,637.00 |
| Sep 30, 2025 | 218,053.00 |
| Jun 30, 2025 | 222,496.00 |
| Mar 31, 2025 | 213,983.00 |
| Dec 31, 2024 | 207,756.00 |
| Sep 30, 2024 | 116,253.00 |
| Jun 30, 2024 | 114,452.00 |
| Mar 31, 2024 | 115,398.00 |
| Dec 31, 2023 | 118,670.00 |
| Sep 30, 2023 | 117,840.00 |
| Jun 30, 2023 | 122,146.00 |
| Mar 31, 2023 | 121,303.00 |
| Dec 31, 2022 | 123,026.00 |
| Mar 31, 2019 | 46,461.00 |